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Objective:  We investigated the protective effects of an adenosine triphosphate–sen-
sitive potassium channel opener nicorandil in the rabbit model of spinal cord
ischemia.
Methods:  Rabbits were randomized into 4 groups (each n = 6): the nicorandil group
(100 µg/kg intravenous nicorandil 10 minutes before ischemia); the glibenclamide
plus nicorandil group (3 mg/kg intravenous glibenclamide, an antagonist of adeno-
sine triphosphate–sensitive potassium channels, 10 minutes before nicorandil
administration); the vehicle group (vehicle alone); and the sham operation group
(without spinal cord ischemia). Spinal cord ischemia was induced by balloon occlu-
sion of the infrarenal abdominal aorta for 15 minutes at 39°C. Neurologic function
was graded into Johnson’s score at 8 hours, 1 day, and 2 days. Histopathologic
examination was performed at 2 days, and the number of intact motor neuron cells
was compared.
Results:  Johnson scores of the glibenclamide plus nicorandil and vehicle groups
were significantly lower than those of the sham operation and nicorandil groups at
each time point, and no statistically significant difference was observed between the
glibenclamide plus nicorandil and vehicle groups. Histopathologic examination
revealed that motor neurons were almost normal in the nicorandil group, whereas
about 55% of motor neurons were lost in the vehicle and glibenclamide plus nico-
randil groups.
Conclusions:  Nicorandil has a protective effect on the ischemic rabbit spinal cord,
and the beneficial effect seems mediated through the activation of adenosine
triphosphate–sensitive potassium channels.
Spinal cord injury remains a serious problem after operations on thedescending and thoracoabdominal aorta. A number of techniques anddrugs that may reduce the ischemia-reperfusion injury of the cord havebeen evaluated both clinically and experimentally, with variable suc-cess.
The adenosine triphosphate–sensitive potassium channels (KATPs) have been
shown to be involved in the mechanisms of ischemic preconditioning in the heart1
and in the brain,2 and KATP openers may thus have protective effects on these
organs. In the brain neuronal cells, protective effects of KATP openers, which are
blocked by their inhibitors, have been reported.3,4 In the spinal cord, however, there
is no report that examines the protective effects of KATP openers. The present study
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was undertaken to examine whether intravenous administra-
tion of nicorandil, a clinically available KATP opener, pro-
tects the spinal cord motor neurons and motor function after
reperfusion.
Material and Methods
Twenty-four male New Zealand White rabbits weighing 2.5 to 3.5
kg were used in this study. The animal protocol was approved by
the Hokkaido University Animal Care and Use Committee and was
in accordance with the “Guide for the Care and Use of Laboratory
Animals” published by the National Academy Press (revised
1996). All experiments were performed in the Research Institute of
Hokkaido University School of Medicine.
Surgical Procedure
The animals were anesthetized with intramuscular administration
of ketamine hydrochloride (50 mg/kg) and maintained with 2%
halothane in 100% oxygen. They were allowed to breathe sponta-
neously with a nonsealing face-mask device. A rectal probe was
inserted to monitor body temperature, which was maintained at
39°C (normal value in our animals) with the aid of a heating pad
(Asahi Plate Warmer TK-43; Asahi Denshi Inc, Osaka, Japan). The
marginal ear vein was cannulated for intravenous drug administra-
tion. The median ear artery was cannulated to obtain arterial blood
samples and to monitor proximal aortic blood pressure. Arterial
blood gas and glucose levels were measured after anesthetic stabi-
lization. Heart rate from the electrocardiogram and arterial blood
pressure were continuously monitored and recorded throughout
the operation.
After intravenous administration of heparin sodium (100
IU/kg), a 4F angiographic balloon catheter (A024; Goodtec,
Huntington Beach, Calif) was introduced through the surgically
isolated left femoral artery into the abdominal aorta to a distance
of 15 cm from the arteriotomy. This distance was decided on so
that the tip of the catheter balloon lay just caudal to the left renal
artery and was confirmed at postmortem examination of the rabbits
killed for catheter placement measurements. Spinal cord ischemia
was induced by inflation of the balloon. Aortic occlusion was con-
firmed by reduction in distal aortic blood pressure, which was
measured through the side hole of the balloon catheter. At the end
of the operation, catheters were removed, surgical wounds were
closed, and the rabbits were allowed to recover at ambient temper-
ature and were returned to their cages.
Experimental Protocol
The rabbits were randomized into 4 groups. In the nicorandil group
(n = 6), 100 µg/kg nicorandil (Chugai Pharmaceutical, Tokyo,
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Japan) was intravenously administered 10 minutes before the rab-
bits underwent 15 minutes of spinal cord ischemia. The 15-minute
ischemic insult and the dosage schedule of nicorandil were based
on results of preliminary experimentation. Arterial blood samples
were collected to measure plasma concentrations of nicorandil,
which were undetectable before administration of the drug and
40.7 ± 4.5 ng/mL at the onset of ischemia. Nicorandil concentra-
tions 10 minutes after reperfusion were 6.2 ng/mL in 2 animals and
undetectable (the minimum detectable level was 5 ng/mL) in the
rest. High-performance liquid chromatography5 was used to deter-
mine plasma concentration.
In the glibenclamide plus nicorandil (G+N) group (n = 6), 3
mg/kg glibenclamide (Wako Pure Chemical Industries, Osaka,
Japan), a blocker of KATPs, was intravenously administered 20
minutes before ischemia, and the animals had a similar time of
ischemia and the same dosage schedule of nicorandil.
Glibenclamide was dissolved in 0.1 N NaOH, and pH was adjust-
ed to 7.6 with 0.1 N HCl.6 Rabbits in the vehicle group (n = 6) had
a similar time of ischemia but received the same volume of saline
solution instead of nicorandil. Rabbits in the sham operation group
(n = 6) underwent similar instrumentation and received the same
volume of saline solution without spinal cord ischemia.
TABLE 1. Arterial blood gas and glucose level before ischemia
Group pH PO2 (mm Hg) PCO2 (mm Hg) Base excess Glucose (mg/dL)
Sham operation 7.36 ± 0.01 436 ± 76 39.3 ± 2.8 –2.8 ± 0.7 115 ± 9
Vehicle 7.38 ± 0.05 443 ± 35 38.6 ± 1.7 –1.7 ± 1.1 110 ± 5
Nicorandil 7.35 ± 0.05 414 ± 55 40.9 ± 2.9 –2.5 ± 0.8 136 ± 6.7
G+N 7.39 ± 0.05 422 ± 25 36.3 ± 1.6 –2.7 ± 1.0 117 ± 17
Figure 1. Neurologic outcome expressed by using the Johnson 5-
point scale.
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Neurologic Assessment
Neurologic function was evaluated at 8 hours, 1 day, and 2 days
after operation. Animal neurologic function was graded on a 5-
point scale according to the method of Johnson and colleagues7: 0,
hind-limb paralysis; 1, severe paraparesis; 2, functional movement
but no hop; 3, ataxia with disconjugate hop; 4, minimal ataxia; and
5, normal function. One member of the research team without
knowledge of the treatment graded neurologic function.
Histopathology
Immediately after neurologic testing at 2 days, the animals were
killed after achievement of deep anesthesia with sodium pentobar-
bital (50 mg/kg administered intravenously), and the spinal cords
were quickly removed. They were fixed by immersion in 2%
paraformaldehyde-15% picric acid in 0.1 mol/L phosphate buffer
and embedded in paraffin. Serial transverse sections (5 µm) were
obtained at the L4-L5 level. They were stained with hematoxylin
and eosin for histopathologic observations. In 4 serial sections of
each rabbit, the total number of motor neurons in the gray matter
was counted and averaged.
Statistical Analysis
Data are expressed as means ± standard error of the mean. Mann-
Whitney rank sum tests were used for nonparametric comparisons
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of the Johnson score between 2 groups. One-way analysis of vari-
ance and Fisher post hoc testing was used for comparison of con-
tinuous variables.
Results
Arterial blood gas and glucose levels before ischemia were
not different among the 4 groups (Table 1). Heart rates,
mean proximal and distal aortic pressures, and rectal tem-
peratures at baseline (before drug treatment), immediately
before aortic occlusion, during aortic occlusion, and 30 min-
utes after reperfusion are shown in Table 2. Heart rates and
mean proximal aortic pressures were not different among
the 4 groups at each time point. In the nicorandil group,
bolus infusion of nicorandil resulted in a transient but sig-
nificant decrease of mean proximal aortic pressure to 72.5 ±
3.4 mm Hg at 5 minutes after drug treatment (P = .014 from
baseline, paired t test), which returned to baseline before
aortic occlusion. By contrast, mean proximal aortic pressure
did not show a significant decrease in the G+N group (72.2
± 4.9 mm Hg at 5 minutes after drug treatment, P = .1167
from baseline, paired t test). Heart rate remained unchanged
in both groups. In the 3 groups with spinal cord ischemia,
mean distal aortic pressure decreased to less than 20 mm Hg
Figure 2. Photomicrographs of the spinal cord stained with hematoxylin and eosin: A, sham operation group; B,
vehicle group; C, nicorandil group; and D, G+N group. (Original magnification, 100×.)
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after balloon inflation, and no pulsation was recorded. The
rectal temperature decreased by 1°C on average during bal-
loon inflation and returned to normal level within 10 min-
utes after reperfusion. No significant difference was found
in these parameters among the 3 groups at each time point.
Neurologic Outcome
Neurologic outcome data are shown in Figure 1. All rabbits
in the sham operation group were normal (grade 5) through-
out the observation period. In the nicorandil group all but 1
of the rabbits had normal neurologic function 8 hours after
operation, and 2 rabbits, including the one with injury at 8
hours, showed functional deterioration 1 and 2 days after
operation. There was no statistically significant difference
between the 2 groups. By contrast, the scores of the G+N
and vehicle groups were significantly lower than those of
the sham operation and nicorandil groups at each time point,
and no statistically significant difference was observed
between the G+N and vehicle groups.
Histopathology
Histopathology data are shown in Figure 2. In the spinal
cord anterior horn of the rabbits in the sham operation group
and those in the nicorandil group, except the 2 with func-
tional deterioration, large motor neurons showed no histo-
logic change. In the vehicle and G+N groups, however, the
number of intact motor neurons decreased, and the remain-
ing motor neurons showed shrinkage and chromatic agglu-
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tination. The total number of motor neurons in the gray mat-
ter was significantly different among the 4 groups (Figure
3). It was significantly lower in the vehicle and G+N groups
than that in the sham operation and nicorandil groups, and
there was no significant difference between the vehicle and
G+N groups and between the sham operation and nicorandil
groups. This result shows good correlation with the Johnson
score at 2 days before animal death.
Discussion
The results of the present study showed that intravenous
administration of nicorandil before ischemia had a protective
effect on the rabbit spinal cord motor neurons and motor
function, and the beneficial effect was lost by glibenclamide
pretreatment. The number of motor neurons was parallel to
the motor function score. Fifteen minutes’ occlusion of
infrarenal abdominal aorta in the rabbit has been used by
Sakurai and colleagues8 as a model of spinal cord ischemia.
They have reported that at 37°C, 40% of rabbits were neuro-
logically intact 2 days after the operation, but no rabbit had
normal neurologic function at 7 days. In our study, however,
no rabbit had normal neurologic function at 2 days, and this
difference may be explained by the higher temperature used
in our study. Suzuki and colleagues6 have reported that intra-
venous administration of the KATP openers nicorandil and
pinacidil accelerates the recovery of reflex potential after
spinal cord ischemia in cats6 but did not evaluate the motor
function. To our knowledge, the present study is the first to
TABLE 2. Heart rate, mean proximal and distal aortic pressure, and rectal temperature
Heart rate (beats/min) Distal MAP (mm Hg) Proximal MAP (mm Hg) Rectal temperature (°C)
Baseline (before drug treatment)
Sham group 296 ± 10 82.3 ± 2.3 77.5 ± 4.7 39.4 ± 0.1
Vehicle group 305 ± 14 85.0 ± 3.9 77.4 ± 4.5 39.4 ± 0.4
Nicorandil group 296 ± 18 87.7 ± 2.8 79.3 ± 2.8 39.5 ± 0.3
G+N group 310 ± 17 81.3 ± 4.5 76.0 ± 6.1 39.5 ± 0.2
Immediately before aortic occlusion
Sham group 299 ± 9 82.7 ± 1.4 77.0 ± 2.1 39.4 ± 0.1
Vehicle group 306 ± 15 82.7 ± 3.4 75.8 ± 3.5 39.3 ± 0.4
Nicorandil group 301 ± 19 84.0 ± 3.0 74.2 ± 2.4 39.2 ± 0.3
G+N group 288 ± 23 85.2 ± 2.9 77.2 ± 5.5 39.2 ± 0.2
During aortic occlusion (10 min)
Sham group 296 ± 7 82.7 ± 1.0 77.7 ± 1.7 39.4 ± 0.1
Vehicle group 302 ± 15 18.0 ± 2.4* 76.0 ± 5.2 38.6 ± 0.3
Nicorandil group 265 ± 26 17.5 ± 1.0* 77.3 ± 1.8 38.7 ± 0.2
G+N group 242 ± 18 14.3 ± 1.0* 78.0 ± 3.8 38.7 ± 0.3
30 min after reperfusion
Sham group 297 ± 7 81.0 ± 4.5 78.3 ± 2.2 39.4 ± 0.1
Vehicle group 314 ± 14 80.7 ± 4.5 75.4 ± 6.0 39.2 ± 0.3
Nicorandil group 278 ± 24 83.7 ± 2.7 76.2 ± 0.9 39.1 ± 0.3
G+N group 283 ± 15 80.7 ± 2.5 76.0 ± 1.1 39.1 ± 0.2
MAP, Mean aortic pressure.
*P < .05 versus sham operation group.
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demonstrate the protective effect of a KATP opener on motor
function in the model of spinal cord ischemia.
Nicorandil is a hybrid drug exerting a dual mechanism of
action as a KATP opener and a nitrate.9 It has been reported
that KATP activation is responsible for the vasodilatory
effects on the resistance vessels, whereas the nitrate action is
predominant in the conductance vessels.10 Therefore these
vasodilatory effects or a direct effect on neuronal KATPs may
have contributed to its protective effect on the ischemic spinal
cord. The nitrate action, however, does not seem involved
because the protective effect of nicorandil was completely
blocked by glibenclamide. Suzuki and colleagues6 have
shown, in the cat model of spinal cord ischemia, that 3 mg/kg
glibenclamide completely blocks the beneficial effect of 100
µg/kg nicorandil but does not have a detrimental effect if
administered alone. Therefore, the protective effects of nico-
randil seem mediated through activation of KATP.
The dosage schedule of nicorandil in the present study was
carefully decided so that the therapeutic plasma concentration
could be obtained at the onset of ischemia but not during the
reperfusion period. Consequently, the plasma concentration
of the drug at the onset of ischemia in this study roughly cor-
responded to that after a single oral dose of 5 mg in the human
subject.11 This was based on the following considerations.
Nitrates and other nitric oxide (NO) donors have been report-
ed to be harmful rather than protective during spinal cord
ischemia, despite their vasodilatory effects.12 In the brain it
has been reported that protective vascular effects of endothe-
lial NO outweigh the neurotoxic potential of neuronal NO
only in the very early stages of ischemia, and large amounts
of NO produced by inducible NO synthase during the late
reperfusion period contribute to the delayed progression of
the damage.13 In the heart Ohno and colleagues14 have report-
ed that nicorandil has a protective effect if it is administered
before ischemia but not if it is administered after ischemia,
and this effect is mediated through the activation of KATP.
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The specific mechanism underlying the beneficial effect of
a KATP opener on the ischemic spinal cord remains to be
clarified. The vasodilatory effect through vascular KATP acti-
vation, hyperpolarization of the neurons through sarcolemnal
KATP activation,3,4 and ischemic tolerance afforded by mito-
chondrial KATP activation may have been involved. Because
nicorandil at this concentration does not seem to dilate the
resistance vessels through KATP activation,15 and both prox-
imal and distal aortic pressures were not different at the
moment of spinal cord ischemia among the 3 groups, we
believe that there was very little contribution of the vasodila-
tory effect. Although we did not measure the regional spinal
cord blood flow, Suzuki and colleagues6 have reported that it
does not show an increase by administration of 30 to 100
µg/kg nicorandil in the cat model of spinal cord ischemia. In
the heart it has been reported that ischemic tolerance afford-
ed by KATP activation is mediated through the mitochondri-
al, rather than the sarcolemmal, KATP.1 Sato and colleagues16
have reported that nicorandil is 100 times more potent in
opening mitochondrial KATPs than in opening sarcolemnal
KATP in the rabbit myocytes. A recent study with diazoxide
and 5-hydroxydecanoic acid, a selective mitochondrial KATP
opener and blocker, has suggested involvement of mitochon-
drial KATPs in the protective effect of KATP openers in the
brain.17 Therefore, we suppose that the protective effect of
nicorandil on the spinal cord is mediated through the mito-
chondrial KATP. Further research works with selective mito-
chondrial KATP openers will be required on this issue.
In the present study we used ketamine and halothane as
anesthetics. Although some volatile anesthetics have been
reported to have cardioprotective effects through their action
on KATPs, halothane has been shown to have neither this
effect18 nor a protective effect on the spinal cord.19 Ketamine,
on the other hand, is a noncompetitive N-methyl-D-aspartate
antagonist and has been reported to have a protective effect on
the spinal cord.19 Therefore, the result of the present study
may have been influenced by the effect of ketamine.
In conclusion, results of the present study show that nico-
randil has a protective effect on the ischemic rabbit spinal
cord, and the beneficial effect seems mediated through the
activation of KATPs.
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